US v. Holmes Verdict: 4 Investor Fraud Convictions, 4 Patient Acquittals, June 2022

The documentary applies selective framing, close-ups, and information ordering to shift viewer perception of Holmes in real time. Court filings from Northern District of California case 18-cr-00258 document the precise split verdict: convictions limited to wire fraud and conspiracy counts involving investors, with explicit acquittals on counts tied to clinical test results. No primary trial exhibits support claims of widespread patient harm as criminal conduct.

Canon 2015 portrait experiment and subsequent media analyses demonstrate that pre-loaded descriptions alter visual interpretation more than subject content. Bad Blood by John Carreyrou and SEC Theranos filings establish the $700 million investor loss figure through documented communications, independent of later dramatizations. The film replicates this mechanism without disclosing its own editorial sequence as a variable.

Operational effect is accelerated erosion of distinction between adjudicated facts and narrative construction in technology coverage. Viewers exit with reinforced priors rather than updated evidence weights. Future regulatory or civil actions against health technology founders will face identical framing risks absent direct access to docket materials.

Streaming platforms report no correction mechanisms for verdict misalignments in commissioned documentaries. Primary records remain the sole verifiable baseline.